Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Smiths Medical Acquires Respiratory Device Firm

By HospiMedica staff writers
Posted on 13 Jul 2004
In a move to expand its portfolio of respiratory products, Smiths Medical (London, UK) has acquired DHD Healthcare (Wampsville, NY, USA) for U.S.$55 million.

DHD's products are used to care for the respiratory needs of patients in a variety of therapeutic and critical care applications. More...
The company had sales of U.S.$21.2 million over the past 12 months. Smiths acquired DHD from Riverside Capital (Cleveland, OH, USA). Smiths Medical is one of the four operating divisions of the Smiths Group plc, which designs and manufactures critical safety systems and products, including medical devices.

"DHD's world class respiratory products will complement and extend the Smiths Medical airway range with high-growth, novel respiratory care devices,” said Lawrence Kinet, managing director of Smiths Medical.





Related Links:
Smiths Medical
DHD Healthcare

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Syringes
Prefilled Saline Flush Syringes
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.